 |
Interactive Masterclass
Management of chronic and allergic pulmonary aspergillosis
Wednesday 25 January 2012
Applications are now being accepted
Places are limited to 35 so early applications are recommended to avoid disappointment.
Applicants must be practicing clinicians, ideally with experience of TB, severe asthma and antifungal usage.
Registration Fee: £100 (*)
(*) SPEAKERS on the main Advances Against Aspergillosis programme will be able to apply free of charge.
To include:
- Dinner on Tuesday 24 January (to meet the faculty and other delegates)
- Attendance at Masterclass
- Tea/coffee throughout the event
- Lunch on Wednesday 25 January
- Workbook
Aims of the Masterclass
- To provide the latest information about chronic and allergic pulmonary aspergillosis
- To provide a framework for clinical decision-making in patients with pulmonary disorders with evidence of aspergillosis
- To outline optimal therapy and how to measure success
- To discuss alternative approaches to therapy because of failure, resistance or toxicity
- To understand overlap syndromes with multiple Aspergillus diseases, co-infections and other mimic diseases
Faculty
Professor David Denning, Professor of Medicine and Medical Mycology, University of Manchester; Director, National Aspergillosis Centre.
Dr Caroline Baxter, Clinical Research Fellow, National Aspergillosis Centre, University Hospital of South Manchester
Dr Timothy Felton, Clinical Research Fellow, National Aspergillosis Centre, University Hospital of South Manchester
Programme
08:30 |
Introduction and plan for the day |
08:45 |
Clinical and radiological presentation, diagnosis – David Denning |
10:00 |
Clinical case quiz (what is the diagnosis?) |
10:30 |
Break |
10:50 |
Disease progression and approaches to therapy – David Denning |
12:00 |
Q & A |
12:30 |
Lunch |
13:15
|
Breakout session with real cases and management conundrums |
14:30 |
Antifungal TDM and azole dose modifications - Timothy Felton |
15:00 |
Break |
15:20 |
Dealing with antifungal toxicities - Caroline Baxter and David Denning |
16:00 |
Clinical failure and its management – David Denning |
16:45 |
Difficult clinical cases – All |
17:15 |
EMQ questions |
17:30 |
Q & A and EMQ answers. |
18:00 |
Close |
Supported by an unrestricted educational grant from Gilead Sciences Europe Ltd.
